Related Experiment Video
Updated: Aug 3, 2026
07:41
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction
Published on: June 7, 2011
[Percutaneous coronary intervention in myocardial infarction. Current concepts]
1Cardiología Intervencionista, Hospital Universitario Gregorio Marañón, Madrid, España. ejgarcia@retemail.es
Revista Espanola De Cardiologia
|May 19, 2005
Summary
Percutaneous coronary intervention (PCI) is the most effective treatment for acute myocardial infarction, superior to thrombolysis. Advanced techniques like stenting and glycoprotein inhibitors further improve outcomes in restoring coronary artery blood flow.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Context:
- Acute ST-segment elevation myocardial infarction requires rapid restoration of coronary artery blood flow.
- Percutaneous coronary intervention (PCI) has emerged as a primary treatment strategy.
Purpose:
- To review the efficacy of percutaneous mechanical reperfusion strategies in acute myocardial infarction.
- To compare PCI with thrombolysis and evaluate the role of adjunct therapies and devices.
Summary:
- Randomized trials confirm PCI's superiority over thrombolysis for ST-elevation myocardial infarction.
- Stent implantation in primary angioplasty yields superior results compared to balloon angioplasty.
- Early glycoprotein IIb/IIIa inhibitors, direct stenting, and devices like X-Sizer improve angiographic outcomes.
- Rescue PCI is indicated for failed thrombolysis, and PCI is the recommended treatment for cardiogenic shock.
Impact:
- PCI significantly improves clinical and angiographic outcomes in acute myocardial infarction.
- The findings support PCI as the gold standard for reperfusion therapy.
- Continued research into preventing myocardial reperfusion injury is warranted.
More Related Videos
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...